Phase II clinical trial of interleukin-2, interferon-alpha and tegafur uracil therapy for advanced renal cell cancer.

Trial Profile

Phase II clinical trial of interleukin-2, interferon-alpha and tegafur uracil therapy for advanced renal cell cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2016

At a glance

  • Drugs Interferon alpha (Primary) ; Interleukin-2 (Primary) ; Tegafur/uracil (Primary)
  • Indications Renal cancer
  • Focus Therapeutic Use
  • Acronyms IATRCC
  • Most Recent Events

    • 31 Mar 2016 Status changed from active, no longer recruiting to completed.
    • 16 Sep 2014 Planned End Date changed from 1 Jun 2014 to 1 Jun 2015 as reported by University Hospital Medical Information Network - Japan.
    • 21 Jan 2014 Status changed from recruiting to active, no longer recruiting, according to University Hospital Medical Information Network (Japan) record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top